Market revenue in 2023 | USD 64.3 million |
Market revenue in 2030 | USD 112.5 million |
Growth rate | 8.3% (CAGR from 2023 to 2030) |
Largest segment | Fish |
Fastest growing segment | CISH |
Historical data | 2018 - 2022 |
Base year | 2023 |
Forecast period | 2024 - 2030 |
Quantitative units | Revenue in USD million |
Market segmentation | FISH, CISH |
Key market players worldwide | Thermo Fisher Scientific Inc, Abbott Laboratories, Agilent Technologies Inc, Merck KGaA, Bio-Rad Laboratories Inc, Bio View Ltd, Revvity Inc |
No credit card required*
Name | Profile | # Employees | HQ | Website |
---|
The databook is designed to serve as a comprehensive guide to navigating this sector. The databook focuses on market statistics denoted in the form of revenue and y-o-y growth and CAGR across the globe and regions. A detailed competitive and opportunity analyses related to in situ hybridization market will help companies and investors design strategic landscapes.
Fish was the largest segment with a revenue share of 53.81% in 2023. Horizon Databook has segmented the France in situ hybridization market based on fish, cish covering the revenue growth of each sub-segment from 2018 to 2030.
Cancer led to more than 185,000 deaths in 2020 and has drawn the attention of research communities for enhancing innovations in disease mitigation. For instance, in May 2021, a collaborative initiative, Onco START, consisting of 12 expert entities in cancer, was set up to drive entrepreneurial innovations in this domain.
Horizon Databook provides a detailed overview of country-level data and insights on the France in situ hybridization market , including forecasts for subscribers. This country databook contains high-level insights into France in situ hybridization market from 2018 to 2030, including revenue numbers, major trends, and company profiles.
Sign up and get instant basic access to databook, upgrade
when ready, or enjoy our
free plan indefinitely.
Included in Horizon account